Carnitine Palmitoyltransferase 2 (CPT2) (N-Term) Peptid
CPT2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle CPT2 Produkte
- CPT2 (Carnitine Palmitoyltransferase 2 (CPT2))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- FNPFMAFNPD PKSEYNDQLT RATNMTVSAI RFLKTLRAGL LEPEVFHLNP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-CPT2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CPT2 (Carnitine Palmitoyltransferase 2 (CPT2))
- Hintergrund
-
The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders.
Alias Symbols: CPT2,CPT1,
Protein Size: 658 - Gen-ID
- 1376
- NCBI Accession
- NP_000089
- UniProt
- P23786
-
Sie sind hier:
